As shown in Fig. 1B, the percentage of Ag+ T cells within CD4+ T cells was similar in all MS patients and HD, confirming that MS patients treated with different drugs mount a detectable specific T cell response. The gene discussed is CD4; the disease is myeloid sarcoma.